| Stereochemistry | ACHIRAL |
| Molecular Formula | C9H8N2O |
| Molecular Weight | 160.1726 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CC1=NC=CC2=C1C=CC(=O)N2
InChI
InChIKey=OCCZJXAHSUCJSA-UHFFFAOYSA-N
InChI=1S/C9H8N2O/c1-6-7-2-3-9(12)11-8(7)4-5-10-6/h2-5H,1H3,(H,11,12)
| Molecular Formula | C9H8N2O |
| Molecular Weight | 160.1726 |
| Charge | 0 |
| Count |
MOL RATIO
1 MOL RATIO (average) |
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
Medorinone is an inhibitor of cAMP phosphodiesterase activity. Inhibition of cAMP phosphodiesterase by medorinone in cardiac and vascular smooth muscle is a mechanism by which this agent produces both positive cardiac inotropy and vascular smooth muscle relaxation. It inhibits platelet aggregation.
Originator
Approval Year
Targets
| Primary Target | Pharmacology | Condition | Potency |
|---|---|---|---|
| 0.55 µM [IC50] |
